Federal grants to Scarab Genomics LLC
Scarab Genomics LLC in Madison, Wisconsin received $5.5 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Allergy and Infectious Diseases Research, with $2.9 million. In fiscal 2025 it was awarded $1.7 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.5 million
- Awards5
- Awarded in FY 2025$1.7 million
- Largest award$1.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $2.0 million |
| FY 2022 | 1 | $961,744 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $842,151 |
| FY 2025 | 2 | $1.7 million |
Programs that fund Scarab Genomics LLC
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $2.9 million |
| Biomedical Research and Research Training | 2 | $2.6 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $5.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Production of antibody therapeutic fragments by reduced genome e. Coli in continuous culture | Allergy and Infectious Diseases Research | June 7, 2021 | $1.9 million |
| An improved low-endotoxin clean genome e. Coli strain for production of biological products - abstract e. Coli has played a vital role in the production of recombinant proteins and plasmid dna (PDNA) for therapeutic use since the advent of the biopharmaceutical industry. E. Coli remains the workhors | Biomedical Research and Research Training | August 28, 2024 | $1.6 million |
| Toxoid adjuvant CRM197 production in a stable reduced genome e. Coli strain | Allergy and Infectious Diseases Research | February 10, 2021 | $1.0 million |
| Development of a continuous microbial fermentation system using reduced genome e. Coli that undergo programmed autolysis and generate nuclease post-production for the manufacture of biopharmaceuticals - continuous bioprocessing that brings with it the advantages of lower ultimate cost, a smaller equ | Biomedical Research and Research Training | September 11, 2025 | $937,537 |
| Increasing available choices for conjugate vaccine technology by producing carrier proteins in scarab genomics? Reduced genome e. Coli strains | Allergy and Infectious Diseases Research | October 29, 2020 | $38,140 |
Questions people ask
How much federal grant money does Scarab Genomics LLC get?
$5.5 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Scarab Genomics LLC the most?
The Department of Health and Human Services, with $5.5 million in 5 awards.
What is Scarab Genomics LLC's largest federal grant?
$1.9 million under Allergy and Infectious Diseases Research, with its first action in the period on June 7, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Scarab Genomics LLC?
Its largest are Allergy and Infectious Diseases Research and Biomedical Research and Research Training.
Other grant recipients in Madison
- State of Wisconsin Department of Health Services
- Wisconsin Department of Public Instruction
- Wisconsin Department of Transportation
- State of Wisconsin Dept of Children & Families
- University of Wisconsin System
- Wisconsin Department of Natural Resources
- Department of Military Affairs Wisconsin
- Public Service Commission of Wisconsin
Largest federal grant recipients in Wisconsin · Federal grants in Wisconsin